|
BOK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.91223999999046E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.622800E-04 |
| Normal-vs-Stage2 |
1.006160E-02 |
| Normal-vs-Stage3 |
3.560300E-03 |
| Normal-vs-Stage4 |
3.64969999999687E-07 |
| Stage1-vs-Stage2 |
4.792600E-01 |
| Stage1-vs-Stage3 |
8.767800E-01 |
| Stage1-vs-Stage4 |
1.934170E-02 |
| Stage2-vs-Stage3 |
4.613200E-01 |
| Stage2-vs-Stage4 |
4.375200E-01 |
| Stage3-vs-Stage4 |
3.312400E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.172900E-04 |
| Normal-vs-AfricanAmerican |
1.32720000001196E-06 |
| Normal-vs-Asian |
4.874500E-02 |
| Caucasian-vs-AfricanAmerican |
1.181950E-02 |
| Caucasian-vs-Asian |
4.292000E-01 |
| AfricanAmerican-vs-Asian |
8.981100E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.492400E-02 |
| Normal-vs-Female |
5.56459999967451E-07 |
| Male-vs-Female |
1.067990E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.580480E-04 |
| Normal-vs-Age(41-60Yrs) |
1.036440E-03 |
| Normal-vs-Age(61-80Yrs) |
2.49599999999628E-05 |
| Normal-vs-Age(81-100Yrs) |
7.145800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.736800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.369200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.071600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.043380E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.798370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.281600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.690200E-01 |
| Classical-VS-Follicular |
2.876200E-02 |
| Classical-VS-Other |
4.733600E-01 |
| Classical-VS-Normal |
3.983900E-04 |
| Tall-VS-Follicular |
1.193550E-01 |
| Tall-VS-Other |
4.322600E-01 |
| Tall-VS-Normal |
1.421820E-01 |
| Follicular-VS-Other |
1.130050E-01 |
| Follicular-VS-Normal |
2.20629999999611E-05 |
| Other-VS-Normal |
9.151400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.973400E-04 |
| Normal-vs-N1 |
3.93919999996939E-06 |
| N0-vs-N1 |
1.100200E-01 |
|
|
